Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
Back
Favorite
Facebook
Tweet
Print
IN VIVO DIRECT REPROGRAMMING OF TUMOR CELLS TO DENDRITIC CELLS AS A NEW CANCER IMMUNOTHERAPY MODALITY
Saturday, July 13, 2024
10:45 AM – 11:05 AM
CEST
Location: Hall 1, Level 2
Plenary Speaker(s)
Cristiana F. Pires, PharmD, PhD
Asgard Therapeutics, Sweden